A Phase 1b Clinical Study of Intravenous AAVrh10 Vector Expressing GALC in Krabbe Subjects Who Previously Received Hematopoietic Stem Cell Transplantation (REKLAIM)
Clinical Trial Grant
Awarded By
Forge Biologics
Start Date
June 13, 2024
End Date
December 31, 2026
Awarded By
Forge Biologics
Start Date
June 13, 2024
End Date
December 31, 2026